NuCana (NCNA) Competitors $0.06 +0.01 (+11.42%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$0.06 0.00 (-0.54%) As of 07/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NCNA vs. PTEIQ, ASLN, CWBR, EVFM, PBLA, PTPI, NMTR, TRVN, HEPA, and SRNEShould you be buying NuCana stock or one of its competitors? The main competitors of NuCana include PolarityTE (PTEIQ), ASLAN Pharmaceuticals (ASLN), CohBar (CWBR), Evofem Biosciences (EVFM), Panbela Therapeutics (PBLA), Petros Pharmaceuticals (PTPI), 9 Meters Biopharma (NMTR), Trevena (TRVN), Hepion Pharmaceuticals (HEPA), and Sorrento Therapeutics (SRNE). These companies are all part of the "pharmaceutical products" industry. NuCana vs. Its Competitors PolarityTE ASLAN Pharmaceuticals CohBar Evofem Biosciences Panbela Therapeutics Petros Pharmaceuticals 9 Meters Biopharma Trevena Hepion Pharmaceuticals Sorrento Therapeutics PolarityTE (NASDAQ:PTEIQ) and NuCana (NASDAQ:NCNA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk. Which has preferable valuation & earnings, PTEIQ or NCNA? PolarityTE has higher revenue and earnings than NuCana. NuCana is trading at a lower price-to-earnings ratio than PolarityTE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarityTE$810K0.00-$7.83M-$3.28N/ANuCanaN/AN/A-$24.28M-$7.02-0.01 Is PTEIQ or NCNA more profitable? PolarityTE's return on equity of -106.08% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets PolarityTEN/A -106.08% -76.91% NuCana N/A -319.85%-88.55% Do insiders and institutionals hold more shares of PTEIQ or NCNA? 11.8% of PolarityTE shares are owned by institutional investors. Comparatively, 44.0% of NuCana shares are owned by institutional investors. 5.4% of PolarityTE shares are owned by insiders. Comparatively, 31.2% of NuCana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts rate PTEIQ or NCNA? NuCana has a consensus price target of $25.00, suggesting a potential upside of 44,864.03%. Given NuCana's stronger consensus rating and higher probable upside, analysts plainly believe NuCana is more favorable than PolarityTE.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PolarityTE 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NuCana 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media prefer PTEIQ or NCNA? In the previous week, PolarityTE's average media sentiment score of 0.00 equaled NuCana'saverage media sentiment score. Company Overall Sentiment PolarityTE Neutral NuCana Neutral Which has more risk and volatility, PTEIQ or NCNA? PolarityTE has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, NuCana has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. SummaryNuCana beats PolarityTE on 7 of the 12 factors compared between the two stocks. Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NCNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCNA vs. The Competition Export to ExcelMetricNuCanaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$300K$2.88B$5.47B$8.95BDividend YieldN/A2.46%5.25%4.06%P/E Ratio-0.0120.8027.0020.10Price / SalesN/A286.98435.75120.29Price / CashN/A41.1936.8257.86Price / Book0.047.487.985.56Net Income-$24.28M-$55.04M$3.16B$248.40M7 Day PerformanceN/A2.44%2.40%4.67%1 Month PerformanceN/A1.90%2.19%6.64%1 Year PerformanceN/A4.35%33.82%21.31% NuCana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCNANuCana2.5042 of 5 stars$0.06+11.4%$25.00+44,864.0%-98.1%$300KN/A-0.0130Gap UpPTEIQPolarityTEN/AN/AN/AN/A$1.24M$810K-0.0560Gap UpASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330CWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010EVFMEvofem Biosciences0.5858 of 5 stars$0.01+4.3%N/A-14.5%$1.16M$11.39M-0.02120Gap DownPBLAPanbela Therapeutics0.093 of 5 stars$0.23+10.4%N/A-57.0%$1.13MN/A0.006PTPIPetros Pharmaceuticals0.6404 of 5 stars$0.03-5.4%N/A-99.7%$1.04M$5.11M-0.0120Gap DownNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220TRVNTrevena1.5868 of 5 stars$1.05-5.4%$5.00+376.2%-83.0%$1.01M$443K-0.0240News CoverageGap DownHigh Trading VolumeHEPAHepion Pharmaceuticals0.5469 of 5 stars$0.08+14.0%N/A-99.9%$874KN/A-0.0220Gap DownSRNESorrento Therapeutics0.6903 of 5 stars$0.00-36.4%N/A-87.3%$772K$60.32M0.00800Gap Down Related Companies and Tools Related Companies PolarityTE Competitors ASLAN Pharmaceuticals Competitors CohBar Competitors Evofem Biosciences Competitors Panbela Therapeutics Competitors Petros Pharmaceuticals Competitors 9 Meters Biopharma Competitors Trevena Competitors Hepion Pharmaceuticals Competitors Sorrento Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NCNA) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
